Manakan Srichai is a Nephrology physician. OpenAlex indexes 9 publications with 732 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7 Cedar Grove Ln
Suite 31
Somerset, NJ 088731331
Telephone
732-873-1400Registry record last updated 3 Aug 2012.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ardelyx, Inc.Program year20251 payment
- Calliditas Therapeutics US Inc.Program year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
87.1%Calcium channel blocker23.5%Amlodipine Besylate60%Nifedipine Er40%Part D<11 patientsLoop diuretic14.9%Furosemide59%Bumetanide41%Part D<11 patients+ 8 more classes in this area
Other
5.3%Potassium Binder2.9%Sodium Polystyrene Sulfonate100%Part D<11 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia2.4%Lokelma100%Part D<11 patientsMusculoskeletal
4.1%Xanthine oxidase inhibitor4.1%Allopurinol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Nonselective Cyclooxygenase Inhibition Retards Cyst Progression in a Murine Model of Autosomal Dominant Polycystic Kidney Disease
International Journal of Medical Sciences
2019 - The Integrin β1 Subunit Regulates Paracellular Permeability of Kidney Proximal Tubule Cells
Journal of Biological Chemistry
2014 - Estimating Baseline Kidney Function in Hospitalized Patients with Impaired Kidney Function
Clinical Journal of the American Society of Nephrology
2012 - Deleting the TGF-β Receptor Attenuates Acute Proximal Tubule Injury
Journal of the American Society of Nephrology
2012
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”